If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
Doctors may tell patients to pop their pills in the morning or evening or perhaps with meals. But a new study finds many genes that direct production of proteins targeted by drugs have a daily cycle of activity driven by the body's circadian rhythms. Medication to manage a hyperactive thyroid, for example, could therefore be most effective if consumed when certain thyroid genes are most active. Conversely, taking the drug when the genes are idle could be ineffective. Also, says Marc D. Ruben, a research fellow at Cincinnati Children’s Hospital, who led the study, smart timing “could reduce the amount of drug needed to achieve a desired effect or lessen side effects at the same dose.”
Credit: Martin Krzywinski; Source: “A Database of Tissue-Specific Rhythmically Expressed Human Genes Has Potential Applications in Circadian Medicine,” by Marc D. Ruben et al., in Science Translational Medicine, Vol. 10; September 12, 2018
It’s Time to Stand Up for Science
If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.
I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.
If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.
